Application no. and date | 01937109.5 (espacenet) (Federated) (European Patent Register), 20010531 | Patent/reg. no. and date | DK/EP 1289992, 20060315 | Publication date | 20030312 | Priority no. and date | GB 0013407, 20000602 | EP pub. no. and date |
EP 1289992 20030312 | Effective date | | Applicant/owner | AstraZeneca AB, S-151 85 Södertälje, SE | Applicant ref. no. | AST 100076 | Inventor | BOHLIN, Martin, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE, COSGROVE, Steve,
AstraZeneca R & D Charnwood, Bakewell Road
Loughborough,
Leics. LE11 5RH, GB, LASSEN, Bo, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE | Representative | | Opponent | | IPC Class | A61K 31/4192 (2006.01) , A61K 31/519 (2006.01) , A61P 7/02 (2006.01) , A61P 9/10 (2006.01) , C07D 487/04 (2006.01) , C07D 239/00 (2006.01) , C07D 249/00 (2006.01) , C07D 487/04 (2006.01) | Title | Ny krystallingsk form af en triazolo(4,5-d)pyrimidinforbindelse | Int. application no. | SE2001001239 | Int. publication no. | WO2001092262 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|